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Women have increased risk of
perioperative myocardial infarction and
higher long-term mortality rates after
lower extremity arterial bypass grafting
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Purpose: The purpose of this study was to determine the effect of gender on the imme-
diate and long-term postoperative morbidity, mortality, and patency rates for infrain-
guinal autogenous vein bypass grafts.
Methods: Data were abstracted for consecutive patients who were followed in a prospec-
tive surveillance protocol after undergoing infrainguinal autogenous vein bypass graft-
ing during the years 1988 to 1994. There were 165 grafts constructed in 148 patients
(101 in 87 men, and 64 in 61 women). Gender differences were analyzed with Student
t test or c 2 test for risk factors, indications for reconstruction, and complications. The
patency rates and the long-term survival rates were compared by means of life-table
analysis. Eagle criteria and long-term survival rates were compared with multivariate
analysis.
Results: The mean follow-up period was 36 months (39 months for men, and 32 months
for women), with a range of 6 to 123 months for the total follow-up period. The two
groups did not differ in age at the time of operation (66.6 ± 1.2 years for men, and 66.7
± 1.5 years for women) or in history of diabetes (48% for men, and 56% for women).
The risks were similar for hypertension (48% for men vs 45% women), preoperative
myocardial infarction (23% for men vs 26% for women), and previous coronary artery
bypass grafting (9% for men vs 8% for women). The thallium stress scintigraphy results
showed a diagnosis of proportionately more preoperative defects in men (reversible, 34%
vs 18%, P < .05; overall, 75% vs 43%, P < .05). The 30-day limb loss rates (0.9% for men,
and 0% for women) and mortality rates (2.2% for men, and 5% for women) were simi-
lar. Women had statistically more perioperative myocardial infarctions than did men (6
of 61, 9.8% vs 2 of 101, 2%; P < .05), as was documented with electrocardiography and
cardiac isoenzymes. Two of these women died within a 30-day postoperative period. The
3-year primary patency rate was 85% for the men and 88% for the women, and the pri-
mary assisted patency rate was 97% for the men and 97% for the women. The secondary
patency rate was 98% for the men and 97% for the women. The limb salvage rate was
slightly higher for the men than for the women (93% vs 87%), although this was not sta-
tistically significant. The 5-year survival rate for women was statistically less than for
men, with life-table analysis (58% for men vs 42% for women; P < .05).
Conclusion: After distal bypass grafting, men and women have similar rates of patency
and limb salvage, but women have a higher incidence rate of perioperative myocardial
infarction and a decreased 5-year survival rate. These data suggest that women have
unrecognized cardiac disease that affects them adversely in the perioperative period and
the long term when compared with men who undergo the same operation. (J Vasc Surg
1999;29:807-13.)
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The impact of gender on the short-term and long-
term outcomes for patients who undergo infrainguinal
bypass grafting surgery for critical ischemia has
received modest attention. Most large series include
both men and women in a combined analysis.
Outcomes traditionally have been by primary, primary
assisted, and secondary patency rates, but the relation-
ship between gender and outcomes, such as cardiac
morbidity and mortality rates, in patients for vascular
surgery is not well defined. More than one half of all
late deaths in patients with lower extremity ischemia
are cardiac in origin.1 Eagle and associates2 stratified
the patients for vascular surgery according to thallium
cardiac imaging and formulated a scoring system for
cardiac risk. This scoring system was compared with
the outcomes in patients who underwent a wide range
of surgical procedures, with different indications and
therefore different inherent risks. Certainly, most sur-
geons would agree, for instance, that carotid
endarterectomy presents less risk to the patient in
terms of perioperative myocardial infarction (MI) than
do more lengthy operative procedures, such as abdom-
inal aortic reconstruction. Therefore, in a comparison
of operative outcomes, it is important to compare
patients who undergo similar procedures. Further-
more, patients with critical lower limb ischemia tend to
have more associated comorbidities, such as congestive
heart failure, renal disease, and diabetes. In this study,
we reviewed our own results for autogenous vein
bypass grafting procedures to compare outcomes, such
as graft patency, perioperative morbidity, and long-
term survival rates, between men and women. We also
stratified patients as to their cardiac risk factors.
Recent studies have reported conflicting data
regarding short-term and long-term patency rates
and patient survival rates when comparing men with
women.3-5 To address these controversies, we
reviewed our own results for autogenous vein bypass
grafting procedures to compare outcomes, including
preoperative dipyridamole-thallium stress (DTST)
cardiac risk assessment, patency rate, perioperative
morbidity rate, and long-term survival rate. This
study presents a homogeneous patient population
who underwent standard operations and therefore
were exposed to similar perioperative stresses.
The value of preoperative cardiac screening to
predict perioperative cardiac events in this high-risk
patient population has been well established.6-8 Our
questions were whether or not women with infrain-
guinal disease have worse outcomes in terms of
patency rate and long-term survival rate after bypass
grafting and whether women in this subset of
patients for vascular surgery have more unrecog-
nized cardiac disease than men. This study addresses
these questions.
PATIENTS AND METHODS
We reviewed the records of consecutive patients
who were followed in a prospective graft surveillance
program after undergoing first time infrainguinal
autogenous vein bypass grafting surgery from the
years 1988 to 1994. All the patients underwent treat-
ment at a single institution by members of the vascu-
lar surgery division at the Medical College of
Wisconsin. The mean follow-up period was 36
months (39 months for men, and 32 months for
women), with a range of 6 to 123 months of the total
follow-up period. There were 165 grafts constructed
in 148 patients—101 men and 64 women. The para-
meters recorded were age at the time of operation,
indications, preoperative and postoperative ankle-
brachial indices, wound complications, and comor-
bidities, such as diabetes, hypertension, previous MI,
and presence or history of smoking. We included
both patients who were not insulin dependent and
patients who were insulin dependent in the group of
patients who were identified as having diabetes.
Our method for preoperative cardiac evaluation
included cardiac clinical history, resting electrocardio-
gram (ECG) results, dipyridamole-thallium scintigra-
phy, and cardiac catheterization. The patients with no
significant cardiac history, defined as previous MI,
arrhythmia, or congestive heart failure, and normal
ECG results underwent no further workup. If the
patients had a significant clinical cardiac history or
abnormal ECG results, they underwent testing with
DTST. We used a liberal interpretation of abnormal
ECG results, which included any changes seen with
ischemic coronary disease, such as ST-T wave depres-
sion or elevation, left ventricular hypertrophy, arrhyth-
mias, and presence of Q waves. If the DTST results were
abnormal, the patients underwent cardiac catheteriza-
tion at the discretion of the consulting cardiologist.
Further preoperative cardiac intervention, such as coro-
nary percutaneous transluminal coronary angioplasty or
revascularization, also was performed after review by
both a cardiologist and a cardiothoracic surgeon. 
DTST assessment was performed with oral and
intravenous administration of dipyridamole. The
patient was closely monitored with ECG, and the
blood pressure was recorded for 1 hour. At the peak
dipyridamole effect, the patient was injected with
thallium 201 and immediate and delayed images
were obtained for comparison. The nuclear radiolo-
gist’s interpretation was used for the determination
of perfusion defects. The scans were defined and read
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as the following: normal, no defects on stress or rest-
ing images; reversible, a defect on stress images that
showed redistribution of thallium so that no defect
was appreciable on resting images; fixed defects, a
defect on stress images that did not change at rest;
and mixed defects, a combination of the previous
defects. Our definition of a significant perioperative
cardiac event was limited to MI, defined by ECG
changes and isoenzyme elevation, or cardiac death.
The resting ECG and DTST results along with
the clinical criteria were used to stratify the patients
into a modified Eagle clinical rating system.2 These
criteria included the presence of angina, arrhyth-
mias, Q-waves or ST depression on resting ECG
results, age of more than 70 years, and presence of
diabetes. All the ECG and DTST results were ana-
lyzed by a single staff cardiologist who was blinded
to the individual patient outcomes. Chronic use of
aspirin, beta blockers, calcium channel blockers,
nitrates, digoxin, vasodilators, and diuretics at the
time of testing also was recorded.
The data were recorded and analyzed with SPSS
for Windows (version 6.0.1, SPSS, Inc, Chicago, Ill).
Mean age, risk factors, indications, medication use,
and cardiac test results were compared with Student t
test or c 2 test. Primary patency was defined as unin-
terrupted patency of the original graft without inter-
vention. Patency of the nonoccluded original graft
with angioplasty or patch graft revision was termed
primary assisted patency. Occluded grafts that were
salvaged were termed secondarily patent. Survival data
were obtained from telephone interviews with
patients and their family members, from death certifi-
cates, and from chart review. Graft patency and sur-
vival rates were compared with life-table analysis.
Multivariate analysis was used to compare Eagle
scores and patients outcomes (True Epistat Statistical
software, Richardson, Tex). A P value of less than .05
was considered significant in all analyses.
RESULTS
Risk factors. The demographics, risk factors,
and presenting characteristics for men and women
are presented in Table I. No significant differences
were noted between the groups for age, diabetes,
hypertension, tobacco use, previous MI, or previous
coronary artery bypass grafting.
Cardiac descriptors. The DTST results and
ECG analysis results are presented in Table II.
Women had a higher frequency of DTST testing
than did men (88% vs 67%). Fourteen of the men
(16%) and 10 of the women (16%) underwent pre-
operative cardiac catheterization. Four of the men
and one of the women underwent preoperative per-
cutaneous transluminal coronary angioplasty. One
man and two women underwent preoperative car-
diac revascularization. The men had more defects as
shown by the DTST and ECG results.
Indications and bypass grafting specifics. The
indications for infrainguinal bypass grafting in both
groups were similar, including nonhealing ulcer (66%
for men, and 62% for women), ischemic rest pain (24%
for men, and 34% for women), severe claudication (5%
for men, and 3% for women), acute ischemia (5% for
men, and 2% for women), and popliteal aneurysm in
one man. The comparative characteristics of the bypass
grafts for men versus for women show a higher inci-
dence rate of tibial bypass grafting procedures in men
(68% vs 50%). The inflow vessels were similar for both
men and women and were the common femoral or
proximal superficial femoral artery in nearly all the
patients. A history of ipsilateral revascularization with
prosthetic graft was present in 9.3% of the women and
in 9.9% of the men. Inflow procedures performed
before bypass grafting were 6.9% in men and 7.8% in
women. The mean preoperative ankle-brachial indices
were 0.40 ± 0.2 for men and 0.38 ± 0.18 for women.
The mean postoperative ankle-brachial indices were
0.84 ± 0.2 for men and 0.79 ± 0.17 for women.
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Table I. Patient demographics
Men Women P value
No. of patients 87 61
Mean age (years) 66.6 ± 1.2 66.7 ± 1.5 NS
Diabetes 42 (48%) 34 (56%) NS
Hypertension 42 (48%) 27 (45%) NS
Tobacco use 62 (71%) 41(66%) NS
Previous MI 20 (23%) 16 (26%) NS
Previous CABG 8 (9%) 5 (8%) NS
NS, Not significant; MI, myocardial infarction; CABG, coronary
artery bypass grafting.
Table II. Cardiac descriptors
No. of men No. of women P value
Fixed defect 14 (25%) 10 (20%) NS
Reversible defect 20 (34%) 9 (18%) .048
Mixed defect 10 (19%) 2 (4%) .017
Any defect 44 (75%) 21 (43%) .000
LVH 17 (19.5%) 9 (14.7%) NS
Q wave on ECG 25 (28.7%) 11 (18%) NS
Nonspecific ST-T 30 (58%) 20 (41%) NS
changes on ECG
NS, Not significant; LVH, left ventricular hypertrophy; ECG,
electrocardiogram.
Perioperative (30-day) outcome. Women had
statistically more perioperative MIs than did men (6
of 61, 9.8%, vs 2 of 87, 2%; P < .05). Two of these
women died as a result of MI. In this group of six
women, two women had undergone cardiac
catheterization just before the leg bypass grafting.
Three of these women had a DTST result alone that
revealed a fixed defect, a reversible defect, and a nor-
mal study before surgery. One woman with diabetes
and a Q-wave by lead III on ECG had no further
cardiac workup but should have undergone testing
with DTST. The two men with MIs had fixed
defects on preoperative DTST results and under-
went no further cardiac evaluation. The wound
complication rate (ie, infection or hematoma that
necessitated operative drainage) was similar between
the groups (11% in both). The 30-day limb loss and
mortality rates were not statistically different (0.9%
for men and 0% for women, and 2.2% for men and
5% for women, respectively).
Three-year graft patency rates and 5-year sur-
vival rates. The 3-year primary patency rate was 85%
(standard error of the mean [SEM], ± 5.1%) in the
men and 88% (SEM, ± 7.7%) in the women, and the
primary assisted patency rate was 97% (SEM, ± 2.4%)
in the men and 97% (SEM, ± 2.9%) in the women.
The secondary patency rate was 98% (SEM, ± 1.9%)
in the men and 97% (SEM, ± 3.3%) in the women.
The limb salvage rate was slightly, but not significant-
ly, better in the women than in the men (93% vs 87%).
There were no statistical differences in the previous
descriptors by means of life-table analysis.
The 5-year survival rate for women was statisti-
cally less than for men with life-table analysis (Fig 1).
The standard error at 60 months was ± 5.6% in the
men and ± 7.0% in the women. The causes of death
for these patients are listed in Table III. These data
were obtained from the patient charts, telephone
interviews with family members, or death certifi-
cates. Documented cardiac death occurred in 6.4%
of the men and 27% of the women. Sudden death
from unknown causes comprised most of the
patients in the male population and one half the
population of women. The patients were placed in
the unknown category if autoposy or accurate evi-
dence was lacking. However, we believe that cardiac
disease played a significant role in most of the
deaths. Cancer was the next leading cause of death
in both groups (6.4% in men and 9.7% in women).
When patient survival rate was compared with
multivariate analysis, DTST results were a poor pre-
dictor of long-term outcomes. However, our modi-
fied Eagle score predicted long-term survival rates in
men but not in women, with multivariate analysis
(c 2, 5.06; P = .024). The difference between men
and women became even more striking when patient
survival rate was analyzed for presence of diabetes
(Fig 2). The standard error at 60 months was ±
10.7% in the men and ± 14.2% in the women. When
diabetes was absent in either gender, there was no
difference in survival rate between groups (Fig 3).
The standard error at 60 months was ± 8.5% in the
men and ± 14.5% in the women.
DISCUSSION
In our study, men had more cardiac disease iden-
tified before surgery with both ECG and DTST cri-
teria, but, paradoxically, women had more postoper-
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Fig 1. Graphic representation comparing 5-year survival
rates of men versus women.
Fig 2. Graphic representation comparing 5-year survival
rates of men versus women with diabetes.
ative MIs and poorer long-term survival rates.
Women with diabetes had the worse survival rates in
our patients.
Dipyridamole thallium imaging in our study was
not predictive of long-term survival rate. We found
that a modified Eagle score was predictive for long-
term survival rate in men but not in women. These
data show that women have latent cardiac disease
that is not being identified by screening with ECG
and DTST. We are unable to explain by this study
why women have a higher incidence rate of unrec-
ognized cardiac disease. The two principle reasons
for this could be that women have a different distri-
bution or that their cardiac disease is less amenable
to detection with DTST. We suspect, but cannot
prove, that the explanation is a combination of these
two reasons.
These results both agree and disagree with the
results of Hendel et al.8 They examined gender as a
variable in 567 patients for vascular surgery (380 men
and 187 women) who underwent screening with pre-
operative dipyridamole thallium imaging. Transient
(reversible) thallium defects had a sensitivity (81% for
men vs 79% for women) and a specificity (68% for
men vs 66% for women) in predicting perioperative
MI or cardiac death. However, the authors did note
that fixed thallium defects were predictive of late car-
diac events in women but not in men.
There were no significant gender differences in
traditional technical outcome measures, including
graft patency rates, limb salvage rates, and wound
complication rates. These findings are similar to
other studies that examined the influence of gender
on outcomes.3,4
In a large study of infrainguinal autogenous vein
graft reconstructions, Harris and colleagues3 report-
ed that men and women had similar rates of primary
graft patency, limb salvage, and mortality. These sur-
vival data were not stratified into patients with dia-
betes versus patients without diabetes. However, the
men in their study had a statistically significant high-
er incidence rate of diabetes and smoking than did
the women. Our population had a similar gender dis-
tribution for diabetes, but we demonstrated poorer
long-term survival rates in our female patients.
Magnant and associates5 reported a marked
decreased survival rate in women with diabetes
(39%) versus without diabetes (78%). Compared
with men, the women in their study were 3 years
older at the time of operation and smoked less but
had a similar incidence rate of hypertension, previ-
ous MI, diabetes, angina, and cerebrovascular dis-
ease. They found decreased primary and secondary
graft patency rates in women versus men. Our study
showed a trend in poorer survival rates in women
with diabetes versus women without diabetes, which
was not significant. In contrast, we found improved
survival rates in men with diabetes as compared with
men without diabetes, but, again, this difference was
not significant. However, we found a significant
decrease in survival rates in women with diabetes as
compared with men. We can only speculate that sur-
vival rate in men is less affected by diabetes than in
women because of factors such as size of coronary
vessels and body surface areas. Indeed, for women,
diabetes is an ominous marker for mortality.
This report does not attempt to assess whether
the recognition and subsequent treatment of cardiac
disease improves patient outcome. Studies of nuclear
imaging have predominantly evaluated male sub-
jects.8-10 Our data suggest that men may have a dif-
ferent response as compared with women. We con-
clude that cardiac disease in women with infrain-
guinal vascular occlusive disease is silent and can be
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Fig 3. Graphic representation comparing 5-year survival
rates of men versus women without diabetes.
Table III. Cause of death
No. of men No. of women
Cardiac 3 (6.4%) 11 (27%)
Stroke 1 (2%) 0
Unknown 38 (81%) 22 (54%)
Ischemic gut 1 (2%) 2 (4.8%)
Cancer 3 (6.4%) 4 (9.7%)
Renal failure 0 2 (4.8%)
Suicide 1 (2%) 0
Total 47 41
unrecognized with screening tests, such as dipyri-
damole stress imaging. We did not detect less cardiac
disease in women for lack of thorough preoperative
investigation. In fact, a higher percentage of women
in this consecutive series underwent screening with
DTST than did the men in the study. In our study,
women with perioperative MIs had variable preoper-
ative results with thallium scintigraphy, including
fixed, reversible, and normal.
Noteworthy in this report is the decrease in
long-term survival rate in women versus men and
the higher rate of perioperative MIs in women,
despite a lower prevalence of objective criteria for
cardiac disease. We conclude that the current meth-
ods of preoperative screening for cardiac disease for
female patients, particularly those with diabetes, fail
to identify a significant subset of patients who will
have a morbid postoperative course and decreased
long-term survival rate.
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Dr Patrick J. O’Hara (Cleveland, Ohio). Thank you,
Dr Mays, for a well analyzed and clearly presented paper.
I basically have two questions. The background for the
first question is that, from our own data, when we looked
at all of our patients with lower extremity atherosclerotic
occlusive disease, we found that 80% of them had under-
gone coronary angiography and about 20% to 25% of that
group required myocardial revascularization. We also
found, considering both men and women, that the 5-year
survival rate in that group was better for men without dia-
betes, but we could not demonstrate a similar improve-
ment for women. And interestingly, when we looked at the
aneurysm data considering both women and men, about
80% of that group had cardiac catheterization and roughly
18% required myocardial revascularization. In your own
data, about 16% of patients ended up with catheterization
and only about 5%, I think, in each group, had some inter-
vention, either percutaneous translumial angioplasty or
coronary bypass grafting. So, the first question is, do you
think the difference in intervention rate had any influence
on the results? In other words, is there some coronary dis-
ease that is not being addressed?
The second question has to do with the data that Dr
Loop published back in 1983 regarding women and men
who had coronary bypass grafting operations. I think
about 2500 women versus 18,000 men were compared,
and the perioperative mortality rate for women was about
twice that for men. But when Dr Loop corrected for age
and body surface area, it turned out that there really was
no gender influence—it had to do with the size, the body
surface area. And so I wonder whether you looked into
that, or if it might be applicable to your data? In other
words, is it mainly size as opposed to gender?
Dr Bradley W. Mays. Thank you Dr O’Hara.
To address your first question, perhaps the coronary
artery disease in our population is not being addressed
because only 16% of the patients in both groups underwent
cardiac catheterization. I think that is certainly a possibili-
ty, and the real question is how aggressive are we going to
be in searching for this disease in these people. Because
even though we can do cardiac catheterization on these
people, only 5% or 10% might actually have disease that is
amenable to treatment, such as percutaneous transluminal
coronary angioplasty or coronary artery bypass grafting.
Our study cannot answer whether or not preoperative
intervention had any influence on outcomes. As for body
surface area, we do not have that data. First of all, I would
only be speculating that the women, for instance, who have
DISCUSSION
the diabetes versus the men with diabetes have a different
course of their coronary artery disease. Many of these
patients are overweight and have type II diabetes. Perhaps
“apple-shaped” women with diabetes have a higher body
surface in relation to relatively small coronary arteries and
this combination places them at a higher risk for fatal car-
diac events.
Dr James J. Schuler (Chicago, Ill). I enjoyed your
paper, but it did raise two questions that might possibly
explain the differences you saw in your women. Did you
look at the incidence rate in the women who had periop-
erative myocardial infarction versus those who did not,
whether or not the group with the higher incidence rate of
myocardial infarction was not taking aspirin, either before,
during, or after surgery because of the protective
antiplatelet aggregating effects? So, in other words, did
you substratify the women in that regard?
The same question regards, did you look at the influ-
ence of estrogen replacement therapy or hormonal
replacement therapy in your group of women who did
have myocardial infarction versus those who did not? Both
of those factors may have an influence on thrombo-
genecity and coronary artery thrombosis.
Dr Mays. We stratified patients according to medica-
tions and looked at that in the men versus the women.
There was no difference in use of aspirin, digoxin, diuret-
ics, or calcium channel blockers. Remarkably, only 8% of
the women in our study were taking estrogen replacement
at the time of operation. This particular factor may have a
larger influence than is currently recognized.
Dr Schuler. The recent Asymptomatic Carotid
Atherosclerosis Study showed a higher perioperative
complication rate among women that tended to lessen
the long-term benefit. Our own analysis of the state of
Michigan aneurysm data over an 11-year period likewise
showed a significantly higher mortality rate, periopera-
tive mortality rate for both elective repair and for repair
of ruptured aneurysms.
Dr Loop’s data to which Dr O’Hara alluded and sev-
eral of the cardiac studies also show increased perioperative
and acute event mortality rates among women. Intrigued
by this, we went back to the laboratory. Interestingly
enough, of course, in most laboratory experiments, one is
trying to eliminate variables. So, it is extraordinarily
uncommon to have comparative studies, particularly with
ischemic type of events, with using all male subjects or all
female subjects, to eliminate some of the biologic variabil-
ity. However, even in the experimental setting, if you sub-
ject a rat or a dog to an hour’s worth of renal ischemia, you
will see significant differences in the ability for the tolerance
of ischemic kidneys. We have gone after the mechanism for
these biologic variables in the laboratory setting, and,
although we do not yet have an answer, we are intrigued by
the possibilities that differences in vasoreactivity or local
thrombogenicity are the answer rather than simply variable
size of the blood vessels. Most of us in our clinical practices
recognize that Raynaud’s phenomenon, angina, and
migraine headaches are more common in women than they
are in men. And we also recognize that there are some dif-
ferential local coagulation effects.
I wonder if you have any data or insight to speculate
about a possible mechanism for the difference? Thank you.
Dr Mays. We were unable to identify a reason for the
difference in survival rates. We can only assume that most
of these people died of acute cardiac events. After
menopause, women lose whatever protective effect estro-
gen provides and catch up to men in overall rate of
myocardial infarction. Certainly, a peripheral vascular dis-
ease is a significant marker for coronary artery disease.
Perhaps, women have a different distribution and severity
of disease, especially when diabetes is present, which places
them at higher risk for fatal events.
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